Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.
View Top Employees from Valo Therapeutics LtdWebsite | http://www.valotx.com |
Revenue | $7.7 million |
Employees | 19 (14 on RocketReach) |
Founded | 2016 |
Address | Viikinkaari 6, Helsinki, Uusimaa 00790, FI |
Phone | +44 20 3920 7649 |
Technologies |
JavaScript,
HTML,
Google Analytics
+13 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Health Care, Business Services, Medical |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Valo Therapeutics Ltd employee's phone or email?
The Valo Therapeutics Ltd annual revenue was $7.7 million in 2024.
Sari Pesonen is the Chief Scientific Officer of Valo Therapeutics Ltd.
14 people are employed at Valo Therapeutics Ltd.
Valo Therapeutics Ltd is based in Helsinki, Uusimaa.
The NAICS codes for Valo Therapeutics Ltd are [541714, 54, 5417, 54171, 541].
The SIC codes for Valo Therapeutics Ltd are [87, 873].